V Wave develops an implant for the treatment of congestive heart failure.
V-Wave has raised €80M across 2 funding rounds from 13 investors, most recently a Series C round in Sep 2020. Based in Caesarea, Israel; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2020-09-23 | Series C | €24M | Deerfield | View deal → |
| 2018-02-01 | Other | €56M | Aperture Venture Partners,BioStar Ventures,BRM Group,Deerfield Management,Edwards Lifesciences,Endeavour Vision+6 more | View deal → |
